BTC $71,807
2026 Bull Run Is Building Start trading with 5% OFF all fees
Sign Up Now
BTC $71,807
Bull Run 2026 | 5% Off Fees Open your Binance account today
Sign Up

Nvidia Gains After $20B Groq Licensing Deal for Inference AI

Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell

  • Stocks rose midday Friday as U.S. markets reopened after the Christmas holiday, with the S&P 500 hitting a fresh high.
  • NVIDIA agreed to a non‑exclusive licensing deal for its inference technology valued at about $20 billion, lifting its shares nearly 2%.
  • Sidus Space, Coupang, Vanda Pharmaceuticals and ImmuCell all saw notable gains after company‑specific news.

U.S. equities traded higher midday Friday as investors returned after the Christmas holiday and the S&P 500 notched a new all‑time high. Markets showed modest ETF gains: the SPDR S&P 500 ETF (SPY) rose 0.08%, the Invesco QQQ Trust (QQQ) gained 0.16%, and the SPDR Dow Jones Industrial Average ETF Trust (DIA) climbed 0.01%.

- Advertisement -

Nvidia Corp. shares rose nearly 2% after the company entered a non‑exclusive licensing agreement with Groq for its inference technology, a deal valued at about $20 billion. Inference technology is software and models that run trained artificial‑intelligence systems to produce outputs from input data.

Sidus Space Inc. jumped more than 22% midday after the firm was awarded a contract under the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) program. SIDU stock has climbed about 237% over the past five trading sessions.

According to Reuters, Coupang Inc. rose over 9% after the company said that “all leaked customer information has been deleted”; Coupang stated the suspect was a former employee. CPNG is up roughly 10% over the past five trading sessions.

Vanda Pharmaceuticals Inc. gained nearly 8% in premarket trading before settling about 3% higher as investors awaited an upcoming U.S. Food and Drug Administration decision on Tradipitant, a motion‑sickness prevention drug. VNDA is up 7% over five sessions.

- Advertisement -

ImmuCell Corp. rose nearly 10% midday after announcing a 50% expansion of its First Defense field sales force and plans to scale up drug manufacturing; the company also said it is pausing its Re‑Tain treatment for cows after receiving an “Incomplete Letter” from the FDA. ICCC is up about 2% over the past five trading sessions.

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

Previous Articles:

- Advertisement -
Ad
Altseason Is Loading. Don't watch from the sidelines.
SOL $90.51
DOGE $0.0963
LINK $9.02
SUI $1.00
5% off fees when you sign up
Start Trading
Ad
Pay Less on Every Trade. For Life.
$10K/mo volume Save $60/yr
$50K/mo volume Save $300/yr
$100K/mo volume Save $600/yr
5% off all trading fees when you sign up
Claim Your Discount

Latest News

SK Hynix Ousts Samsung As South Korea’s Top Valued Firm

SK Hynix became South Korea's most valuable listed company on June 22, 2026, with...

Polymarket Paid Creators for Fake Bet Videos: WSJ

An investigation found dozens of social media creators were paid to film themselves placing...

AryStinger Botnet Hijacks Old Routers for Spying

A new malware called AryStinger has infected at least 4,300 older home routers, according...

Bitcoin Retreats to $62K Amid Global Conflict, Inflation Fears

Bitcoin plunged to the $62,000-$63,000 range in early June 2026, erasing gains from a...

Bitcoin Nears $64K Despite Iran Tensions, Trader Caution

Bitcoin regained the $64,000 level despite renewed geopolitical tensions involving the US, Iran, and...

Must Read

26 Best Investment Audiobooks on Audible

Looking to expand your financial knowledge? Me too..When I first started investing, I was completely lost. There were so many terms, strategies, and theories...
Ad
Altseason Is Loading. These 4 coins are trending right now.
SOL $92.12
DOGE $0.0950
LINK $9.02
SUI $1.02
5% off spot fees when you sign up
Start Trading